Publications by authors named "Keertie S Kularatne"

Acquired hemophilia A (AHA) is a different bleeding disorder to that of classic hemophilia A. It is an autoimmune-mediated bleeding disorder due to the presence of autoantibodies (inhibitors) directed against plasma coagulation factor VIII. This can result in fatal hemorrhage; thus, eradication of the antibody is the mainstay of treatment.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Keertie S Kularatne"

  • - Keertie S Kularatne's research primarily focuses on acquired hemophilia A (AHA), an autoimmune bleeding disorder characterized by the development of antibodies against factor VIII, leading to significant hemorrhagic risks.
  • - One of the key findings highlighted in Kularatne's article examines a case of retrobulbar hemorrhage as a complication of AHA, emphasizing the severity and potential consequences of this condition.
  • - The research underscores the critical need for effective management strategies to eradicate the autoantibodies in AHA patients to prevent life-threatening bleeding episodes, which is central to the treatment approach.